Clinical Rheumatology

, Volume 23, Issue 4, pp 355–357 | Cite as

A case of anti-Jo1 myositis with pleural effusions and pericardial tamponade developing after exposure to a fermented Kombucha beverage

Case Report

Abstract

The pathogenesis of the idiopathic inflammatory myopathies has been postulated to be an environmental trigger causing the expression of the disease in a genetically predisposed patient. We report a case of anti-Jo1 antibody-positive myositis which was associated with pleural effusions, pericardial effusion with tamponade, and ‘mechanic’s hands’, probably related to the consumption of a fermented Kombucha beverage. Kombucha ‘mushroom’, a symbiosis of yeast and bacteria, is postulated to be the trigger for our patient’s disease owing to the proximity of his symptoms to the consumption of the Kombucha beverage.

Keywords

Anti-Jo1 Antisynthetase Kombucha  Myositis 

Abbreviations

ALT

Alanine transferase

AST

Aspartate aminotransferase

CPK

Creatinine phosphokinase

References

  1. 1.
    Stamets P (1994) My adventure with the blob. Mushroom – the Journal (Winter):5–9Google Scholar
  2. 2.
    Unexplained severe illness possibly associated with consumption of Kombucha tea, Iowa 1995. MMWR 1995; 44:892–893, 899–900Google Scholar
  3. 3.
    Mayser P, Fromme S, Leitzmann C, Grunder K (1995) The yeast spectrum of the ‘tea fungus Kombucha’. Mycoses 38:289–295PubMedGoogle Scholar
  4. 4.
    Perron AD, Patterson JA, Yanofsky NN (1995) Kombucha’ mushroom’ hepatotoxicity [letter]. Ann Emerg Med 26:660–661Google Scholar
  5. 5.
    Srinivasan R, Smolinske S, Greenbaum D (1997) Probable gastrointestinal toxicity of Kombucha tea: is this beverage healthy or harmful? J Gen Intern Med 12:643–644CrossRefPubMedGoogle Scholar
  6. 6.
    Phan TG, Estell J, Duggin G, Beer I, Smith D, Ferson MJ (1998) Lead poisoning from drinking Kombucha tea brewed in a ceramic pot. Med J Aust 169:644–646PubMedGoogle Scholar
  7. 7.
    Sadjadi J (1998) Cutaneous anthrax associated with the Kombucha’ mushroom’ in Iran. JAMA 280:1567–1568CrossRefPubMedGoogle Scholar
  8. 8.
    Maddison PJ (1996) Aminoacyl-tRNA histidyl (Jo-1) synthetase autoantibodies. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. Elsevier Science, Amsterdam,pp. 31–35Google Scholar
  9. 9.
    Depper JM, Zvaifler NJ (1981) Epstein–Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis. Arthritis Rheum 24:755–761PubMedGoogle Scholar
  10. 10.
    Braun J, Laitko S, Treharne J et al. (1994) Chlamydia pneumoniae – a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 53:100–105PubMedGoogle Scholar
  11. 11.
    Miller FW, Hess EV, Clauw DJ et al. (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:243–249CrossRefPubMedGoogle Scholar
  12. 12.
    Food and Drug Administration (1995) FDA cautions consumers on’ Kombucha Mushroom Tea’ [News release]. Washington, DC: US Department of Health and Human Services, Public Health Service, Food and Drug AdministrationGoogle Scholar

Copyright information

© Clinical Rheumatology 2004

Authors and Affiliations

  • Chris T. Derk
    • 1
  • Nora Sandorfi
    • 1
  • Mark T. Curtis
    • 2
  1. 1.Division of RheumatologyThomas Jefferson University HospitalPhiladelphiaUSA
  2. 2.Department of PathologyThomas Jefferson University HospitalPhiladelphiaUSA

Personalised recommendations